Global Yellow Fever Treatment Market Size to Grow by USD 663.8

New York, USA, Oct. 26, 2022 (GLOBE NEWSWIRE) — According to a research report published by Spherical Insights & Consulting, the Global Yellow Fever Treatment Market Size to grow from USD 470.5 billion in 2021 to USD 663.8 billion by 2030, at a compound annual growth rate (CAGR) of 3.9% over the forecast period. The yellow fever treatment market has grown due to the rise of Aedes aegypti mosquito which causes flu-like illness. Asia-Pacific is expected to experience the fastest growth over the forecast period.

Get a sample PDF brochure: https://www.sphericalinsights.com/request-sample/1222

The Intermediate Yellow Fever Segment to Account for the Largest Market Size During the Forecast Period

Based on the type of transmission, the yellow fever treatment market is categorized into intermediate yellow fever, sylvatic yellow fever, urban yellow fever, and others. The intermediate yellow fever segment accounts for the largest market size during the forecast period. Intermediate yellow fever virus is an arbovirus of the flavivirus genus. These mosquitoes belong to the Aedes and Haemogogus species and are the carriers of the virus. Additionally, rising demand for arbovirus growth is propelling the growth of the segment.

10% proton pump inhibitor segment to maintain higher CAGR over the forecast period

Based on drugs, the Yellow Fever Treatment Market is categorized into proton pump inhibitors, antipyretics, histamine H2 antagonists and others. The proton pump inhibitors segment will maintain a higher CAGR during the forecast period. Proton pump inhibitor accounted for the highest revenue in the market owing to the increasing focus on preventing infection from patient to patient. Proton pump inhibitors have been shown to be useful in the treatment of yellow fever. Proton pump inhibitors provide fluids and oxygen, maintain adequate blood pressure, replace blood loss, provide dialysis for kidney failure, and treat any other infections that develop.

The Hospitals segment will maintain a higher CAGR during the forecast period.

Based on the end-user, the yellow fever treatment market is classified as specialty clinics, hospitals, home care, and others. The skin hospital segment is expected to maintain a higher CAGR during the forecast period. As hospitals are the major places of treatment for yellow fever patients and more and more people are getting yellow fever vaccinations due to their increased awareness, this market segment is expected to generate the most revenue.

Browse key industry information spread across 215pages with 154 market data tables and The figures & graphics of the report” Global Yellow Fever Treatment Market SizeShare and Analysis of the impact of COVID-19 by type of transmission (intermediate yellow fever, sylvatic yellow fever, urban yellow fever and others), by type of treatment (drugs, vaccination and others), by type of drug (inhibitors antipyretics, histamine H2 antagonists and others), by route of administration (injectable, oral and others), by end users (specialty clinics, hospitals, home care and others), by distribution (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy and Others) and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030″ in detail with the Table of Contents

Buy Now Full Report: https://www.sphericalinsights.com/checkout/1222

North America will maintain a higher CAGR during the forecast period.

The yellow fever treatment market has been segmented into five major regions: North America, Europe, APAC, Latin America and MEA. North America is estimated to account for the highest market share in 2022. Due to increasing number of research and development activities by various small and medium enterprises in North America to establish medical care facilities, the yellow fever treatment market has developed. In addition, the United States has maintained a low rate for its research and development tax credit, which contributes to an increase in market demand for the treatment of yellow fever.

Key companies and recent developments: The report also provides elaborate analysis focusing on current business news and developments, including product development, innovations, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and others. This helps to assess the overall competition in the market. Main suppliers in the world Yellow Fever Treatment Market include Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, FSUE Chumakov.

Related report:

Small Molecule Injectable Drugs Market Size, Share, Analysis, Forecast 2030

https://www.sphericalinsights.com/reports/small-molecule-injectable-drugs-market

Veterinary Pain Management Market Size, Share, Analysis, Forecast 2030

https://www.sphericalinsights.com/reports/veterinary-pain-management-market

Global Allergy Immunotherapy Market Size, Share, Analysis, Forecast 2030

https://www.sphericalinsights.com/reports/allergy-immunotherapy-market

Global Alzheimer’s Disease Diagnostics and Therapeutics Market Size, Share, Analysis, Forecast 2030

https://www.sphericalinsights.com/reports/alzheimers-disease-diagnostics-and-therapeutics-market

For more information about your target market, please contact us below:

Call: +1 303 800 4326 (USA)

Call: +91 90289 24100 (APAC)

E-mail: [email protected], [email protected]

Contact us: https://www.sphericalinsights.com/contact us

Follow us: LinkedIn | Facebook | Twitter